Cargando…
Caveolin-1 sensitizes rat pituitary adenoma GH3 cells to bromocriptine induced apoptosis
BACKGROUND: Prolactinoma is the most frequent pituitary tumor in humans. The dopamine D(2 )receptor agonist bromocriptine has been widely used clinically to treat human breast tumor and prolactinoma through inhibition of hyperprolactinemia and induction of tumor cell apoptosis, respectively, but the...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1832175/ https://www.ncbi.nlm.nih.gov/pubmed/17331262 http://dx.doi.org/10.1186/1475-2867-7-1 |